Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial-Reference-Cited by-同舟云学术

Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial

Published:2018-12 Issue:12 Volume:18 Page:1319-1328
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Portsmouth Simon,van Veenhuyzen David,Echols Roger,Machida Mitsuaki,Ferreira Juan Camilo Arjona,Ariyasu Mari,Tenke Peter,Nagata Tsutae Den

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference27 articles.

1. Carbapenemase genes and genetic platforms in Gram-negative bacilli: Enterobacteriaceae, Pseudomonas and Acinetobacter species;Diene;Clin Microbiol Infect,2014

2. Current epidemiology and growing resistance of Gram-negative pathogens;Livermore;Korean J Intern Med,2012

3. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen;Brooke;Clin Microbiol Rev,2012

4. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control;Tängdén;J Intern Med,2015

5. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases;Munoz-Price;Lancet Infect Dis,2013

Cited by 311 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of carbapenems and alternative antimicrobials for treating complicated urinary tract infections caused by third-generation cephalosporin-resistant gram-negative bacteria: A systematic review and meta-analysis of randomised controlled trials;Journal of Infection and Chemotherapy;2024-11

2. Pharmacokinetics, Safety and Tolerability of Single-dose or Multiple-dose Cefiderocol in Hospitalized Pediatric Patients Three Months to Less Than Eighteen Years Old With Infections Treated With Standard-of-care Antibiotics in the PEDI-CEFI Phase 2 Study;Pediatric Infectious Disease Journal;2024-09-04

3. Cefiderocol: a first and novel class of siderophore cephalosporin for Carbapenem-resistant Gram-negative infection;Folia Pharmacologica Japonica;2024-09-01

4. Should we, and how to, optimize cefiderocol administration during severe nosocomial pneumonia due to carbapenem-resistant Acinetobacter baumanii? A viewpoint;Journal of Global Antimicrobial Resistance;2024-09

5. Enterococci independently increase the risk for initial antibiotic treatment failure and prolonged hospitalization in adult patients with complicated urinary tract infection: a retrospective cohort study;Infection;2024-08-28